Get the Stockscreener App
20.63
0.42%
-0.0877
After Hours:
20.63
-0.0009
-0.00%
Cartesian Growth Corp stock is traded at $20.63, with a volume of 0.
It is down -0.42% in the last 24 hours and up +13.35% over the past month.
See More
Previous Close:
$20.72
Open:
$20.6309
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+2.59%
1M Performance:
+13.35%
6M Performance:
-0.16%
1Y Performance:
+0.00%
1-Day Range:
$20.63
$20.63
1-Week Range:
$20.19
$20.72
52-Week Range:
$17.90
$22.30
Cartesian Growth Corp Stock (GLBL) Company Profile
Compare GLBL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GLBL
Cartesian Growth Corp
|
20.63 | 0 | 0 | 0 | 0 | 0.00 |
|
LION
Lionsgate Studios Corp
|
6.83 | 2.01B | 3.13B | 50.80M | 555.00M | 0.1772 |
|
AACT
Ares Acquisition Corporation Ii
|
11.26 | 695.30M | 0 | 16.92M | -1.35M | 0.29 |
|
ANSC
Agriculture Natural Solutions Acquisition Corp
|
10.72 | 461.01M | 0 | 1.30M | 0 | 0.0301 |
|
AAM
Aa Mission Acquisition Corp
|
10.31 | 453.37M | 0 | 0 | 0 | 0.00 |
|
EQV
Eqv Ventures Acquisition Corp
|
10.20 | 453.30M | 0 | 0 | 0 | 0.00 |
Cartesian Growth Corp Stock (GLBL) Latest News
Berkley W R Corp Lowers Position in Cartesian Growth Co. II (NASDAQ:RENE) - MarketBeat
Cartesian Growth Corp II extends business combination period - Investing.com Australia
Opening Day: Smart Digital, Yuanbao make debuts - TipRanks
Gores Group's Latest SPAC Leads 3 IPOs Totaling $792M - Law360
Cartesian Growth Corp II extends business combination period By Investing.com - Investing.com South Africa
IPO NewsUS IPO Weekly Recap: Flurry of SPACs list and submit filings amid otherwise quiet IPO market - renaissancecapital.com
Cartesian Growth Corporation III Announces Pricing of Upsized $240 Million Initial Public Offering - Business Wire
Cartesian Growth Co. II (NASDAQ:RENE) Shares Sold by Crossingbridge Advisors LLC - MarketBeat
Spartan Fund Management Inc. Invests $295,000 in Cartesian Growth Co. II (NASDAQ:RENE) - MarketBeat
200,000 Shares in Cartesian Growth Co. II (NASDAQ:RENE) Acquired by Alpine Global Management LLC - MarketBeat
Cartesian Growth Co. II (NASDAQ:RENE) Trading Down 0%Time to Sell? - MarketBeat
Cartesian Robot Market to Grow at 7.1% CAGR, Valued at US$ 5.4 Billion by 2033 - openPR.com
Cartesian Growth Co. II (NASDAQ:RENE) Shares Down 0% – Time to Sell? - Defense World
Cartesian Warehouse Robotic Market will Touch New Development Level | ABB, KUKA, Fanuc, Yaskawa - newstrail.com
Cartesian Growth Co. II (NASDAQ:RENEU) Stock Price Down 0.4% – Should You Sell? - Defense World
RENE stock hits 52-week high at $11.89 amid market optimism - Investing.com Australia
Cartesian Growth Corp II extends business combination deadline By Investing.com - Investing.com South Africa
Cartesian Growth Corp II extends business combination deadline - Investing.com Australia
(RENE) Investment Analysis - news.stocktradersdaily.com
Brokerages Set Cartesian Therapeutics, Inc. (NASDAQ:RNAC) PT at $42.14 - Defense World
5 Hot Stock Buys for Investors in April - The Globe and Mail
Cartesian Growth Corp II SEC 10-K Report - TradingView
Cartesian Therapeutics, Inc. (NASDAQ:RNAC) Holdings Raised by Bank of New York Mellon Corp - Defense World
(RENE) Long Term Investment Analysis - news.stocktradersdaily.com
RENE stock hits 52-week high at $11.86 amid growth optimism - Investing.com India
RENE stock hits 52-week high at $11.86 amid growth optimism By Investing.com - Investing.com South Africa
Mizuho Securities USA LLC Increases Holdings in Cartesian Growth Co. II (NASDAQ:RENE) - MarketBeat
Cartesian Growth Co. II (NASDAQ:RENE) Shares Sold by Periscope Capital Inc. - MarketBeat
RENE stock hits 52-week high at $11.83 amid market optimism - Investing.com Australia
RENE stock hits 52-week high at $11.83 amid market optimism By Investing.com - Investing.com South Africa
Global Gantry (Cartesian) Robot Market Poised to Reach USD 23.4 Billion by 2031 Amid Rising Automation Trends - WhaTech
Cartesian Growth Co. II (NASDAQ:RENE) Short Interest Update - MarketBeat
Learn to Evaluate (RENE) using the Charts - Stock Traders Daily
Cantor Fitzgerald maintains Overweight on Cartesian Therapeutics - Investing.com
Cantor Fitzgerald maintains Overweight on Cartesian Therapeutics By Investing.com - Investing.com UK
Cartesian Therapeutics Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Cartesian Growth Co. II (NASDAQ:RENE) Short Interest Down 25.0% in February - MarketBeat
Cartesian Growth Corp Stock (GLBL) Financials Data
There is no financial data for Cartesian Growth Corp (GLBL). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.41%
0.20%
Cap:
|
Volume (24h):